Presentation Title: Anticoagulant Related Bleeding: From DOACs to Novel FXI Inhibitors
Speaker: Harish Eswaran, MD
Date: Thursday, September 3, 2026
Time: 12:00 PM – 1:00 PM
Location: MSB 2.103
Learning Format: In-Person and Online
Series Objectives:
- Apply the latest evidence with patients and practice evidence-based medicine.
- Discuss current research and its potential for application to patient care.
- Discuss the latest clinical practice guidelines relevant to clinical practice.
Activity Objectives:
At the conclusion of this activity, participants should be able to:
- Identify the impact and limitations of direct oral anticoagulants in the management of thrombotic conditions.
- Apply strategies for managing anticoagulant related bleeding.
- Describe the status of clinical trials of FXI inhibitors in various thrombotic pathologies.
Credit Designation:
- McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Event Disclosures:
Speakers:
Harish Eswaran, MD has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Planners and other Administrative Support:
Karla Abela, PhD, RN, CCRN, CPN, Aastha V Bharwad, MD, Latese McCowan, MA, Andrew Sullivan, MD, Carley Allen, MD, Philip Orlander, MD, Gabriel Aisenberg, MD, Jeffrey Chen, MD, Mark A Farnie, MD, Robby Wesley, DO, FACP, Jillian Smith, MD, and Cristina M Natha, MD have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
Commercial Support:
This activity is not commercially supported.
Accreditation Statement:
- McGovern Medical School at the University of Texas Health Science Center at Houston is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.